CXCR1/2 antagonism is protective during influenza and post-influenza pneumococcal infection

Frontiers in Immunology

Volumn 8, Issue DEC, 2017, Pages

  Tavares, Luciana P ^a   Garcia, Cristiana C ^b   Machado, Marina G ^a   Queiroz Junior, Celso M ^a   Barthelemy, Adeline ^c   Trottein, François ^c   Siqueira, Marilda M ^b   Brandolini, Laura ^d   Allegretti, Marcello ^d   Machado, Alexandre M ^b   de Sousa, Lirlândia P ^b   Teixeira, Mauro M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIV LILLE   (France)

^d Chemistry Section   (Italy)

Author keywords

CXCR1 2; Immunomodulation; Inflammation; Influenza A; Pneumococcus; Secondary infection

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 12;

ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; FLOW CYTOMETRY; HEMAGGLUTINATION INHIBITION; HISTOLOGY; HUMAN; INFLAMMATION; INFLUENZA A VIRUS; LETHALITY; LUNG INFECTION; LUNG INJURY; LUNG LAVAGE; MACROPHAGE; MALE; MORBIDITY; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLAQUE ASSAY; PNEUMOCOCCAL INFECTION; PNEUMONIA; SECONDARY INFECTION; STREPTOCOCCUS PNEUMONIAE; VIRUS INFECTION; WEIGHT REDUCTION;

EID: 85037989786     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01799     Document Type: Article

References (55)

1. Kopf M, Schneider C, Nobs SP. The development and function of lung-resident macrophages and dendritic cells. Nat Immunol (2015) 16(1):36-44. doi:10.1038/ni.3052
2. Garcia CC, Guabiraba R, Soriani FM, Teixeira MM. The development of anti-inflammatory drugs for infectious diseases. Discov Med (2010) 10(55):479-88
3. Gupta RK, George R, Nguyen-Van-Tam JS. Bacterial pneumonia and pandemic influenza planning. Emerg Infect Dis (2008) 14(8):1187-92. doi:10.3201/eid1408.070751
4. Short KR, Habets MN, Hermans PW, Diavatopoulos DA. Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship? Future Microbiol (2012) 7(5):609-24. doi:10.2217/fmb.12.29
5. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev (2006) 19(3):571-82. doi:10.1128/CMR.00058-05
6. Madhi SA, Klugman KP, Vaccine Trialist G. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med (2004) 10(8):811-3. doi:10.1038/nm1077
7. Karlström A, Heston SM, Boyd KL, Tuomanen EI, McCullers JA. Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza. J Infect Dis (2011) 204(9):1358-66. doi:10.1093/infdis/jir522
8. Wang JP, Bowen GN, Padden C, Cerny A, Finberg RW, Newburger PE, et al. Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood (2008) 112(5):2028-34. doi:10.1182/blood-2008-01-132860
9. José R, Williams A, Sulikowski M, Brealey D, Brown J, Chambers R. Regulation of neutrophilic inflammation in lung injury induced by community-acquired pneumonia. Lancet (2015) 385(Suppl 1):S52. doi:10.1016/S0140-6736(15)60367-1
10. Camp JV, Jonsson CB. A role for neutrophils in viral respiratory disease. Front Immunol (2017) 8:550. doi:10.3389/fimmu.2017.00550
11. Russo RC, Garcia CC, Teixeira MM, Amaral FA. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases. Expert Rev Clin Immunol (2014) 10(5):593-619. doi:10.1586/1744666X.2014.894886
12. Ramos I, Fernandez-Sesma A. Modulating the innate immune response to influenza A virus: potential therapeutic use of anti-inflammatory drugs. Front Immunol (2015) 6:361. doi:10.3389/fimmu.2015.00361
13. Tavares LP, Garcia CC, Vago JP, Queiroz-Junior CM, Galvão I, David BA, et al. Inhibition of PDE4 during pneumococcal pneumonia reduces inflammation and lung injury in mice. Am J Respir Cell Mol Biol (2015) 55(1):24-34. doi:10.1165/rcmb.2015-0083OC
14. Cunha TM, Barsante MM, Guerrero AT, Verri WA Jr, Ferreira SH, Coelho FM, et al. Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice. Br J Pharmacol (2008) 154(2):460-70. doi:10.1038/bjp.2008.94
15. Garcia CC, Russo RC, Guabiraba R, Fagundes CT, Polidoro RB, Tavares LP, et al. Platelet-activating factor receptor plays a role in lung injury and death caused by influenza A in mice. PLoS Pathog (2010) 6(11):e1001171. doi:10.1371/journal.ppat.1001171
16. Russo RC, Guabiraba R, Garcia CC, Barcelos LS, Roffê E, Souza AL, et al. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol (2009) 40(4):410-21. doi:10.1165/rcmb.2007-0364OC
17. Mihara K, Spansier M, Rooseboom M, Smit MJ, Dokter W. Functional replacement of murine CXCR2 by its human homologue in the development of atherosclerosis in LDLR knockout mice. Biol Pharm Bull (2007) 30(7):1231-6. doi:10.1248/bpb.30.1231
18. Fu W, Zhang Y, Zhang J, Chen WF. Cloning and characterization of mouse homolog of the CXC chemokine receptor CXCR1. Cytokine (2005) 31(1):9-17. doi:10.1016/j.cyto.2005.02.005
19. Klein EY, Monteforte B, Gupta A, Jiang W, May L, Hsieh YH, et al. The frequency of influenza and bacterial co-infection: a systematic review and meta-analysis. Influenza Other Respir Viruses (2016) 10(5):394-403. doi:10.1111/irv.12398
20. Palacios G, Hornig M, Cisterna D, Savji N, Bussetti AV, Kapoor V, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One (2009) 4(12):e8540. doi:10.1371/journal.pone.0008540
21. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med (2009) 361(20):1935-44. doi:10.1056/NEJMoa0906695
22. Dominguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA (2009) 302(17):1880-7. doi:10.1001/jama.2009.1536
23. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis (2008) 198(7):962-70. doi:10.1086/591708
24. Tasher D, Stein M, Simões EA, Shohat T, Bromberg M, Somekh E. Invasive bacterial infections in relation to influenza outbreaks, 2006-2010. Clin Infect Dis (2011) 53(12):1199-207. doi:10.1093/cid/cir726
25. Blok DC, van der Sluijs KF, Florquin S, de Boer OJ, van 't Veer C, de Vos AF, et al. Limited anti-inflammatory role for interleukin-1 receptor like 1 (ST2) in the host response to murine postinfluenza pneumococcal pneumonia. PLoS One (2013) 8(3):e58191. doi:10.1371/journal.pone.0058191
26. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis (2007) 44(Suppl 2):S27-72. doi:10.1086/511159
27. Tuomanen E, Rich R, Zak O. Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am Rev Respir Dis (1987) 135(4):869-74. doi:10.1164/arrd.1987.135.4.869
28. Estenssoro E, Ríos FG, Apezteguía C, Reina R, Neira J, Ceraso DH, et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med (2010) 182(1):41-8. doi:10.1164/201001-0037OC
29. Ghoneim HE, McCullers JA. Adjunctive corticosteroid therapy improves lung immunopathology and survival during severe secondary pneumococcal pneumonia in mice. J Infect Dis (2014) 209(9):1459-68. doi:10.1093/infdis/jit653
30. Sawant KV, Xu R, Cox R, Hawkins H, Sbrana E, Kolli D, et al. Chemokine CXCL1-mediated neutrophil trafficking in the lung: role of CXCR2 activation. J Innate Immun (2015) 7(6):647-58. doi:10.1159/000430914
31. Ritzman AM, Hughes-Hanks JM, Blaho VA, Wax LE, Mitchell WJ, Brown CR. The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis. Infect Immun (2010) 78(11):4593-600. doi:10.1128/IAI.00798-10
32. McAuley JL, Kedzierska K, Brown LE, Shanks GD. Host immunological factors enhancing mortality of young adults during the 1918 influenza pandemic. Front Immunol (2015) 6:419. doi:10.3389/fimmu.2015.00419
33. Planagumà A, Domènech T, Pont M, Calama E, García-González V, López R, et al. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation. Pulm Pharmacol Ther (2015) 34:37-45. doi:10.1016/j.pupt.2015.08.002
34. Lopes AH, Brandolini L, Aramini A, Bianchini G, Silva RL, Zaperlon AC, et al. DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain. Pharmacol Res (2016) 103:69-79. doi:10.1016/j.phrs.2015.11.005
35. Boppana NB, Devarajan A, Gopal K, Barathan M, Bakar SA, Shankar EM, et al. Blockade of CXCR2 signalling: a potential therapeutic target for preventing neutrophil-mediated inflammatory diseases. Exp Biol Med (Maywood) (2014) 239(5):509-18. doi:10.1177/1535370213520110
36. Wareing MD, Shea AL, Inglis CA, Dias PB, Sarawar SR. CXCR2 is required for neutrophil recruitment to the lung during influenza virus infection, but is not essential for viral clearance. Viral Immunol (2007) 20(3):369-78. doi:10.1089/vim.2006.0101
37. DeBerge MP, Ely KH, Cheng GS, Enelow RI. ADAM17-mediated processing of TNF-alpha expressed by antiviral effector CD8+ T cells is required for severe T-cell-mediated lung injury. PLoS One (2013) 8(11):e79340. doi:10.1371/journal.pone.0079340
38. Seki M, Kohno S, Newstead MW, Zeng X, Bhan U, Lukacs NW, et al. Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia. J Immunol (2010) 184(3):1410-8. doi:10.4049/jimmunol.0901709
39. Bou Ghanem EN, Clark S, Roggensack SE, McIver SR, Alcaide P, Haydon PG, et al. Extracellular adenosine protects against Streptococcus pneumoniae lung infection by regulating pulmonary neutrophil recruitment. PLoS Pathog (2015) 11(8):e1005126. doi:10.1371/journal.ppat.1005126
40. Echchannaoui H, Frei K, Letiembre M, Strieter RM, Adachi Y, Landmann R. CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection. J Leukoc Biol (2005) 78(3):705-15. doi:10.1189/jlb.0205063
41. Herbold W, Maus R, Hahn I, Ding N, Srivastava M, Christman JW, et al. Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection. Infect Immun (2010) 78(6):2620-30. doi:10.1128/IAI.01169-09
42. Pittet LA, Hall-Stoodley L, Rutkowski MR, Harmsen AG. Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. Am J Respir Cell Mol Biol (2010) 42(4):450-60. doi:10.1165/rcmb.2007-0417OC
43. Peltola VT, Murti KG, McCullers JA. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis (2005) 192(2):249-57. doi:10.1086/430954
44. Rynda-Apple A, Robinson KM, Alcorn JF. Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease. Infect Immun (2015) 83(10):3764-70. doi:10.1128/IAI.00298-15
45. McNamee LA, Harmsen AG. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect Immun (2006) 74(12):6707-21. doi:10.1128/IAI.00789-06
46. Vlahos R, Stambas J, Selemidis S. Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy. Trends Pharmacol Sci (2012) 33(1):3-8. doi:10.1016/j.tips.2011.09.001
47. Narayana Moorthy A, Narasaraju T, Rai P, Perumalsamy R, Tan KB, Wang S, et al. In vivo and in vitro studies on the roles of neutrophil extracellular traps during secondary pneumococcal pneumonia after primary pulmonary influenza infection. Front Immunol (2013) 4:56. doi:10.3389/fimmu.2013.00056
48. Walsh KB, Teijaro JR, Wilker PR, Jatzek A, Fremgen DM, Das SC, et al. Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci U S A (2011) 108(29):12018-23. doi:10.1073/pnas.1107024108
49. Tavares LP, Teixeira MM, Garcia CC. The inflammatory response triggered by influenza virus: a two edged sword. Inflamm Res (2017) 66(4):283-302. doi:10.1007/s00011-016-0996-0
50. Gavard J, Hou X, Qu Y, Masedunskas A, Martin D, Weigert R, et al. A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. Mol Cell Biol (2009) 29(9):2469-80. doi:10.1128/MCB.01304-08
51. Zhang S, Rahman M, Zhang S, Qi Z, Herwald H, Thorlacius H, et al. Simvastatin regulates CXC chemokine formation in streptococcal M1 protein-induced neutrophil infiltration in the lung. Am J Physiol Lung Cell Mol Physiol (2011) 300(6):L930-9. doi:10.1152/ajplung.00422.2010
52. Reutershan J, Morris MA, Burcin TL, Smith DF, Chang D, Saprito MS, et al. Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. J Clin Invest (2006) 116(3):695-702. doi:10.1172/JCI27009
53. Smith MW, Schmidt JE, Rehg JE, Orihuela CJ, McCullers JA. Induction of pro-and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. Comp Med (2007) 57(1):82-9
54. van der Sluijs KF, Nijhuis M, Levels JH, Florquin S, Mellor AL, Jansen HM, et al. Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. J Infect Dis (2006) 193(2):214-22. doi:10.1086/498911
55. Barthelemy A, Ivanov S, Fontaine J, Soulard D, Bouabe H, Paget C, et al. Influenza A virus-induced release of interleukin-10 inhibits the anti-microbial activities of invariant natural killer T cells during invasive pneumococcal superinfection. Mucosal Immunol (2016) 10(2):460-9. doi:10.1038/mi.2016.49